Ethics by Architecture: Building Ethical Data Governance in Life Sciences

GDPR’s recitals, the AI Act’s preamble and sector-specific frameworks explicitly articulate the values they are designed to protect. Normative content, including human dignity, autonomy and the right to informational self-determination, is on the face of the instrument. The challenge is not identifying it but giving it operational effect inside complex companies and institutions at a pace that regulation alone cannot match. Technological development is outrunning regulatory frameworks. This gap is most acutely felt in life sciences, where clinical research, real-world evidence and cross-border trial data flows create governance challenges existing instruments were not designed to address. Data ethics fills the space where law runs out. This session proposes three embedded governance components: ethical decision triggers, escalation architecture and ethical legibility. Built on existing privacy and AI governance instruments, such as DPIAs, accountability frameworks, and data stewardship models, they surface ethical questions in addition to legal ones. This session interrogates each pillar through structured dialogue with senior practitioners in life sciences and pharma.

What you will learn:

• Where existing compliance architecture fails to surface ethically contested decisions and what structural components close that gap in life sciences data governance. 
• What the three pillars of ethics by architecture require in practice and how they build upon existing governance instruments. 
• How data ethics addresses emerging risks where technology is outpacing regulation and how to make that architecture defensible to regulators and boards.